Nucleic Acids Research, 2001, Vol. 29, No. 22 4598-4606
© 2001 Oxford University Press
Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation
Department of Biochemistry and Molecular Biology, USC/Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, 1441 Eastlake Avenue, Room 8302L, Los Angeles, CA 90089-9181, USA
Silencing of tumor-suppressor genes by hypermethylation of promoter CpG islands is well documented in human cancer and may be mediated by methyl-CpG-binding proteins, like MeCP2, that are associated in vivo with chromatin modifiers and transcriptional repressors. However, the exact dynamic between methylation and chromatin structure in the regulation of gene expression is not well understood. In this study, we have analyzed the methylation status and chromatin structure of three CpG islands in the p14(ARF)/p16(INK4A) locus in a series of normal and cancer cell lines using methylation-sensitive digestion, MspI accessibility in intact nuclei and chromatin immunoprecipitation (ChIP) assays. We demonstrate the existence of an altered chromatin structure associated with the silencing of tumor-suppressor genes in human cancer cell lines involving CpG island methylation, chromatin condensation, histone deacetylation and MeCP2 binding. The data showed that MeCP2 could bind to methylated CpG islands in both promoters and exons; MeCP2 does not interfere with transcription when bound at an exon, suggesting a more generalized role for the protein beyond transcriptional repression. In the absence of methylation, it is demonstrated that CpG islands located in promoters versus exons display marked differences in the levels of acetylation of associated histone H3, suggesting that chromatin remodeling can be achieved by methylation-independent processes and perhaps explaining why non-promoter CpG islands are more susceptible to de novo methylation than promoter islands.
* To whom correspondence should be addressed. Tel: +1 323 865 0816; Fax: +1 323 865 0102; Email: jones_p{at}ccnt.hsc.usc.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Zhou, L. Han, G. Li, and T. Tong Senescence delay and repression of p16INK4a by Lsh via recruitment of histone deacetylases in human diploid fibroblasts Nucleic Acids Res., June 26, 2009; (2009) gkp533v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kholod, J. Boniver, and P. Delvenne A New Dimethyl Sulfoxide-Based Method for Gene Promoter Methylation Detection J. Mol. Diagn., November 1, 2007; 9(5): 574 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. De-Castro Arce, E. Gockel-Krzikalla, and F. Rosl Retinoic Acid Receptor beta Silences Human Papillomavirus-18 Oncogene Expression by Induction of de Novo Methylation and Heterochromatinization of the Viral Control Region J. Biol. Chem., September 28, 2007; 282(39): 28520 - 28529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhang, A. Darwanto, T. A. Linkhart, L. C. Sowers, and L. Zhang Maternal Cocaine Administration Causes an Epigenetic Modification of Protein Kinase C{epsilon} Gene Expression in Fetal Rat Heart Mol. Pharmacol., May 1, 2007; 71(5): 1319 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Claus, M. Fliegauf, M. Stock, J. A. Duque, M. Kolanczyk, and M. Lubbert Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression J. Leukoc. Biol., December 1, 2006; 80(6): 1462 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Ting, K. M. McGarvey, and S. B. Baylin The cancer epigenome--components and functional correlates Genes & Dev., December 1, 2006; 20(23): 3215 - 3231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Searles Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression Am J Physiol Cell Physiol, November 1, 2006; 291(5): C803 - C816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lopez-Serra, E. Ballestar, M. F. Fraga, M. Alaminos, F. Setien, and M. Esteller A Profile of Methyl-CpG Binding Domain Protein Occupancy of Hypermethylated Promoter CpG Islands of Tumor Suppressor Genes in Human Cancer. Cancer Res., September 1, 2006; 66(17): 8342 - 8346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Okino, D. Pookot, L.-C. Li, H. Zhao, S. Urakami, H. Shiina, M. Igawa, and R. Dahiya Epigenetic Inactivation of the Dioxin-Responsive Cytochrome P4501A1 Gene in Human Prostate Cancer. Cancer Res., August 1, 2006; 66(15): 7420 - 7428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fatemi, M. M. Pao, S. Jeong, E. N. Gal-Yam, G. Egger, D. J. Weisenberger, and P. A. Jones Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level Nucleic Acids Res., November 27, 2005; 33(20): e176 - e176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Z. Fang, D. Chen, Y. Sun, Z. Jin, J. K. Christman, and C. S. Yang Reversal of Hypermethylation and Reactivation of p16INK4a, RAR{beta}, and MGMT Genes by Genistein and Other Isoflavones from Soy Clin. Cancer Res., October 1, 2005; 11(19): 7033 - 7041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Auriol, L.-M. Billard, F. Magdinier, and R. Dante Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus Nucleic Acids Res., July 28, 2005; 33(13): 4243 - 4254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Fish, C. C. Matouk, A. Rachlis, S. Lin, S. C. Tai, C. D'Abreo, and P. A. Marsden The Expression of Endothelial Nitric-oxide Synthase Is Controlled by a Cell-specific Histone Code J. Biol. Chem., July 1, 2005; 280(26): 24824 - 24838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Whitman, S. Liu, T. Vukosavljevic, L. J. Rush, L. Yu, C. Liu, M. I. Klisovic, K. Maharry, M. Guimond, M. P. Strout, et al. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy Blood, July 1, 2005; 106(1): 345 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Raval, D. M. Lucas, J. J. Matkovic, K. L. Bennett, S. Liyanarachchi, D. C. Young, L. Rassenti, T. J. Kipps, M. R. Grever, J. C. Byrd, et al. TWIST2 Demonstrates Differential Methylation in Immunoglobulin Variable Heavy Chain Mutated and Unmutated Chronic Lymphocytic Leukemia J. Clin. Oncol., June 10, 2005; 23(17): 3877 - 3885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. N. Bhalla Epigenetic and Chromatin Modifiers As Targeted Therapy of Hematologic Malignancies J. Clin. Oncol., June 10, 2005; 23(17): 3971 - 3993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Izumi, J. Inoue, S. Yokoi, H. Hosoda, T. Shibata, M. Sunamori, S. Hirohashi, J. Inazawa, and I. Imoto Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers Hum. Mol. Genet., April 15, 2005; 14(8): 997 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kim, B. N. Trinh, T. I. Long, S. Oghamian, and P. W. Laird Dnmt1 deficiency leads to enhanced microsatellite instability in mouse embryonic stem cells Nucleic Acids Res., October 27, 2004; 32(19): 5742 - 5749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Lund and M. van Lohuizen Epigenetics and cancer Genes & Dev., October 1, 2004; 18(19): 2315 - 2335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chan, J. E. Fish, C. D'Abreo, S. Lin, G. B. Robb, A.-M. Teichert, F. Karantzoulis-Fegaras, A. Keightley, B. M. Steer, and P. A. Marsden The Cell-specific Expression of Endothelial Nitric-oxide Synthase: A ROLE FOR DNA METHYLATION J. Biol. Chem., August 13, 2004; 279(33): 35087 - 35100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Valinluck, H.-H. Tsai, D. K. Rogstad, A. Burdzy, A. Bird, and L. C. Sowers Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2) Nucleic Acids Res., August 9, 2004; 32(14): 4100 - 4108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Sonoda, I. Imoto, J. Inoue, T. Shibata, Y. Shimada, K. Chin, M. Imamura, T. Amagasa, J. W. Gray, S. Hirohashi, et al. Frequent Silencing of Low Density Lipoprotein Receptor-Related Protein 1B (LRP1B) Expression by Genetic and Epigenetic Mechanisms in Esophageal Squamous Cell Carcinoma Cancer Res., June 1, 2004; 64(11): 3741 - 3747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Liang, J. C. Y. Lin, V. Wei, C. Yoo, J. C. Cheng, C. T. Nguyen, D. J. Weisenberger, G. Egger, D. Takai, F. A. Gonzales, et al. Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome PNAS, May 11, 2004; 101(19): 7357 - 7362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kriaucionis and A. Bird The major form of MeCP2 has a novel N-terminus generated by alternative splicing Nucleic Acids Res., March 19, 2004; 32(5): 1818 - 1823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Weisenberger, M. Velicescu, J. C. Cheng, F. A. Gonzales, G. Liang, and P. A. Jones Role of the DNA Methyltransferase Variant DNMT3b3 in DNA Methylation Mol. Cancer Res., January 1, 2004; 2(1): 62 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Satoh, M. Toyota, F. Itoh, Y. Sasaki, H. Suzuki, K. Ogi, T. Kikuchi, H. Mita, T. Yamashita, T. Kojima, et al. Epigenetic Inactivation of CHFR and Sensitivity to Microtubule Inhibitors in Gastric Cancer Cancer Res., December 15, 2003; 63(24): 8606 - 8613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Obata, M. Toyota, A. Satoh, Y. Sasaki, K. Ogi, K. Akino, H. Suzuki, M. Murai, T. Kikuchi, H. Mita, et al. Identification of HRK as a Target of Epigenetic Inactivation in Colorectal and Gastric Cancer Clin. Cancer Res., December 15, 2003; 9(17): 6410 - 6418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Z. Fang, Y. Wang, N. Ai, Z. Hou, Y. Sun, H. Lu, W. Welsh, and C. S. Yang Tea Polyphenol (-)-Epigallocatechin-3-Gallate Inhibits DNA Methyltransferase and Reactivates Methylation-Silenced Genes in Cancer Cell Lines Cancer Res., November 15, 2003; 63(22): 7563 - 7570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kriaucionis and A. Bird DNA methylation and Rett syndrome Hum. Mol. Genet., October 15, 2003; 12(90002): R221 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Toyota, Y. Sasaki, A. Satoh, K. Ogi, T. Kikuchi, H. Suzuki, H. Mita, N. Tanaka, F. Itoh, J.-P. J. Issa, et al. Epigenetic inactivation of CHFR in human tumors PNAS, June 24, 2003; 100(13): 7818 - 7823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Moreau, G. Mouillot, P. Rousseau, C. Marcou, J. Dausset, and E. D. Carosella HLA-G gene repression is reversed by demethylation PNAS, February 4, 2003; 100(3): 1191 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kondo, L. Shen, and J.-P. J. Issa Critical Role of Histone Methylation in Tumor Suppressor Gene Silencing in Colorectal Cancer Mol. Cell. Biol., January 1, 2003; 23(1): 206 - 215. [Abstract] [Full Text]
|
|
|
|
|
|
J. A. Fahrner, S. Eguchi, J. G. Herman, and S. B. Baylin Dependence of Histone Modifications and Gene Expression on DNA Hypermethylation in Cancer Cancer Res., December 15, 2002; 62(24): 7213 - 7218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ghoshal, J. Datta, S. Majumder, S. Bai, X. Dong, M. Parthun, and S. T. Jacob Inhibitors of Histone Deacetylase and DNA Methyltransferase Synergistically Activate the Methylated Metallothionein I Promoter by Activating the Transcription Factor MTF-1 and Forming an Open Chromatin Structure Mol. Cell. Biol., December 1, 2002; 22(23): 8302 - 8319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. T. Nguyen, D. J. Weisenberger, M. Velicescu, F. A. Gonzales, J. C. Y. Lin, G. Liang, and P. A. Jones Histone H3-Lysine 9 Methylation Is Associated with Aberrant Gene Silencing in Cancer Cells and Is Rapidly Reversed by 5-Aza-2'-deoxycytidine Cancer Res., November 15, 2002; 62(22): 6456 - 6461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Koizume, K. Tachibana, T. Sekiya, S. Hirohashi, and M. Shiraishi Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells Nucleic Acids Res., November 1, 2002; 30(21): 4770 - 4780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ballestar and M. Esteller The impact of chromatin in human cancer: linking DNA methylation to gene silencing Carcinogenesis, July 1, 2002; 23(7): 1103 - 1109. [Abstract] [Full Text] [PDF]
|
|